Increased circulating RANTES in type 2 diabetes
Marzena Dworacka1, Ewa Krzyz̀agórska2, Saule Iskakova3, Yerbol Bekmukhambetov4, Olzhas Urazayev4, Grzegorz Dworacki5
European Cytokine Network, Vol.25, No.3, pp. 46-51, 2014, DOI:10.1684/ecn.2014.0355
Abstract Aim:The pro-atherogenic role of RANTES, a chemokine expressing pleiotropic activities, in the course
of type 2 diabetes-related atherosclerosis has been well documented. However, it is not known which of the diabetes-related
factors primarily influence serum RANTES levels in patients with type 2 diabetes. Our aim was to investigate
relationships between several factors known to be related to an increased risk of atherosclerosis and serum RANTES
levels in type 2 diabetic patients. Methods: A total of 168 subjects were examined, which included 138 patients
with type 2 diabetes and 30 non-diabetic controls. Measurements of venous, fasting,… More >